CTSF

Cathepsin F · Q9UBX1 · CTSF on Sugi Atlas →

13,079 patent compounds predicted against CTSF, 8,933 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL2953108 SCHEMBL2953108 1.00 18/20
SCHEMBL3759357 SCHEMBL3759357 1.00 18/20
SCHEMBL2951583 SCHEMBL2951583 0.84 17/20
SCHEMBL2155109 SCHEMBL2155109 0.83 17/20
SCHEMBL3760063 SCHEMBL3760063 0.84 16/20
SCHEMBL2925461 SCHEMBL2925461 0.74 16/20
SCHEMBL3760635 SCHEMBL3760635 1.00 15/20
SCHEMBL3760637 SCHEMBL3760637 1.00 15/20
SCHEMBL3760645 SCHEMBL3760645 1.00 15/20
SCHEMBL2926229 SCHEMBL2926229 0.82 15/20
SCHEMBL2926231 SCHEMBL2926231 0.82 15/20
SCHEMBL2926232 SCHEMBL2926232 0.82 15/20
SCHEMBL3138544 SCHEMBL3138544 0.68 15/20
SCHEMBL2156856 SCHEMBL2156856 0.88 14/20
SCHEMBL2926034 SCHEMBL2926034 0.83 14/20
SCHEMBL2926037 SCHEMBL2926037 0.83 14/20
SCHEMBL2926040 SCHEMBL2926040 0.83 14/20
SCHEMBL2927165 SCHEMBL2927165 0.79 14/20
SCHEMBL2922410 SCHEMBL2922410 0.56 14/20
SCHEMBL2944796 SCHEMBL2944796 0.87 13/20

Clinical trials — most relevant to CTSF by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Doxycycline In Lymphangioleiomyomatosis (LAM) PHASE4COMPLETED
Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation PHASE4COMPLETED
Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 PHASE2/PHASE3UNKNOWN
Sterile Amniotic Fluid Filtrate Epidural Injection. PHASE1/PHASE2COMPLETED
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis nanCOMPLETED
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD nanNOT_YET_RECRUITING
Usefulness of the Variation of the CLIF-C ACLF Score in Patients With Acute on Chronic Liver Failure nanUNKNOWN
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients nanRECRUITING
Ultrasound Measures and Clinical Outcomes in Healthy Individuals, Mild and Moderate Carpal Tunnel Syndrome Patients nanCOMPLETED
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome nanRECRUITING
Synovial Fluid Bank From Arthritic Patients nanRECRUITING
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
Proteases in Patients With Prostate Cancer That Has Spread to the Bone nanCOMPLETED
Chemokine Mechanisms in Chronic Pelvic Pain nanCOMPLETED
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study nanRECRUITING
SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease nanUNKNOWN
Fasting, Exercise, and Diet to Activate Autophagy in Depression nanNOT_YET_RECRUITING
Screening of Lysosomal Storage Disorders Diseases in Minority Groups nanUNKNOWN
Periodontal Health in Post COVID-19 Patients nanUNKNOWN
Acute Pancreatitis Targets (APT) Study nanCOMPLETED
Influence of Statins in Artery Aneurysms nanUNKNOWN
Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study nanNOT_YET_RECRUITING
Utility of Presepsin in Children Sepsis nanUNKNOWN
Role of A Disintegrin and Metalloproteinase (ADAM) in Epithelial Dysfunction nanCOMPLETED
Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma nanUNKNOWN
Disorders of the Acute Phase Response Following Trauma and Invasive Surgery nanENROLLING_BY_INVITATION
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a CTSF binder may also engage these)

ProteinNameSimilarity
Q9R013 1.000 Q9R013 →
P56202 0.989 P56202 →
P56203 0.988 P56203 →
Q9TST1 0.986 Q9TST1 →
O46427 0.981 O46427 →
Q3T0I2 0.978 Q3T0I2 →
Q8VYS0 0.977 Q8VYS0 →
CTSH Pro-cathepsin H 0.977 landscape →
P49935 0.977 P49935 →
Q96SM3 0.977 Q96SM3 →
Q5RB02 0.976 Q5RB02 →
Q80YC5 0.976 Q80YC5 →
Q07104 0.976 Q07104 →
F7 Coagulation factor VII 0.976 landscape →
LOXL3 Lysyl oxidase homolog 3 0.975 landscape →
Q3U435 0.975 Q3U435 →
Q9Z1W4 0.975 Q9Z1W4 →
O97507 0.974 O97507 →
P00743 0.974 P00743 →
Q2F9P2 0.974 Q2F9P2 →
P23276 0.974 P23276 →
D3ZTE0 0.974 D3ZTE0 →
Q9Z100 0.974 Q9Z100 →
Q499S5 0.974 Q499S5 →
Q8BM88 0.973 Q8BM88 →
CTSC Dipeptidyl peptidase 1 0.973 landscape →
Q9VN93 0.973 Q9VN93 →
Q9Z217 0.973 Q9Z217 →
A0A286YEC0 0.973 A0A286YEC0 →
Q924C6 0.972 Q924C6 →